# Trade Mark Journal No.2026/035 28 August 2026

## WO0000001932372 (5)

Office of origin: United States of America

Date of International Registration:14 July 2026
Date of designation in the UK: 14 July 2026

International priority date claimed: 13 July 2026 (United States of America) (99936830)

Class 5
  Pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of immune system related diseases and disorders.

Viridian Therapeutics, Inc.

Representative: Valerie Brennan Plave Koch PLC, 3120 Fairview Park Drive, Suite 420, Falls Church VA 22042, UNITED STATES OF AMERICA